FDA Working with Manufacturers to Address IV Solutions Shortage

Comments
Print

The Food and Drug Administration (FDA) says it is aware of the shortage situation for intravenous (IV) solutions, particularly 0.9 percent sodium chloride injection (i.e., saline) used to provide patients with the necessary fluids for hydration and other conditions. The shortage has been triggered by a range of factors including a reported increased demand by hospitals, potentially related to the flu season.

We are working with the three manufacturers of these products, Baxter Healthcare Corp., B.Braun Medical Inc., and Hospira Inc., to help preserve the supply of these necessary products. Addressing this shortage will depend on the increased demand and the manufacturing production of the current suppliers. Millions of these I.V. solutions are used each week by healthcare professionals.

For additional information, customers can also contact the firms directly.

Source: FDA

Comments
comments powered by Disqus